{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T01:08:47Z","timestamp":1792372127040,"version":"4.4.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.leukres.2022.106839","type":"journal-article","created":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T20:53:27Z","timestamp":1648846407000},"page":"106839","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Incidence of myelodysplastic syndromes in Finland 1997\u20132016"],"prefix":"10.1016","volume":"116","author":[{"given":"Suvi","family":"Kontro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jani","family":"Raitanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimmo","family":"Porkka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anssi","family":"Auvinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9936","key":"10.1016\/j.leukres.2022.106839_bib1","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/S0140-6736(13)61901-7","article-title":"Myelodysplastic syndromes","volume":"383","author":"Ad\u00e8s","year":"2014","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.leukres.2022.106839_bib2","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1056\/NEJMp048266","article-title":"Myelodysplastic syndromes \u2013 coping with ineffective hematopoiesis","volume":"352","author":"Cazzola","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.leukres.2022.106839_bib3","unstructured":"Swerdlow SH, Campo E., Harris NL, Jaffe ES, Pileri SA, Stein H., Thiele J., Vardiman JW. , 2008. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: International Agency for Research on Cancer; 2008."},{"key":"10.1016\/j.leukres.2022.106839_bib4","series-title":"Schottenfeld and Fraumeni Cancer Epidemiology and Prevention","article-title":"Leukemias","author":"Linet","year":"2018"},{"issue":"19","key":"10.1016\/j.leukres.2022.106839_bib5","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1056\/NEJMra0902908","article-title":"Myelodysplastic syndromes","volume":"361","author":"Tefferi","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.leukres.2022.106839_bib6","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.leukres.2012.08.007","article-title":"Historical perspectives on myelodysplastic syndromes","volume":"36","author":"Steensma","year":"2012","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2022.106839_bib7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","article-title":"Proposals for the classification of the myelodysplastic syndromes","volume":"51","author":"Bennett","year":"1982","journal-title":"Br. J. Haematol."},{"issue":"11","key":"10.1016\/j.leukres.2022.106839_bib8","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.clml.2016.08.005","article-title":"Changes in the updated 2016: WHO classification of the myelodysplastic syndromes and related myeloid neoplasms","volume":"16","author":"Bennett","year":"2016","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"11","key":"10.1016\/j.leukres.2022.106839_bib9","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1002\/cncr.28641","article-title":"Underestimation of myelodysplastic syndrome incidence by cancer registries: results from a population-based data linkage study","volume":"120","author":"McQuilten","year":"2014","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.leukres.2022.106839_bib10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/BF02994001","article-title":"Epidemiological features of myelodysplastic syndromes: Results from regional cancer surveys and hospital-based statistics","volume":"73","author":"Aul","year":"2001","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.leukres.2022.106839_bib11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.canep.2016.12.005","article-title":"Trends of classification, incidence, mortality, and survival of MDS patients in Switzerland between 2001 and 2012","volume":"46","author":"Bonadies","year":"2017","journal-title":"Cancer Epidemiol."},{"issue":"5","key":"10.1016\/j.leukres.2022.106839_bib12","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.ejca.2013.12.002","article-title":"Trends in incidence, initial treatment and survival of myelodysplastic syndromes: a population-based study of 5144 patients diagnosed in the Netherlands from 2001 to 2010","volume":"50","author":"Dinmohamed","year":"2014","journal-title":"Eur. J. Cancer"},{"issue":"12","key":"10.1016\/j.leukres.2022.106839_bib13","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.leukres.2011.06.001","article-title":"Incidence and prevalence of myelodysplastic syndromes: data from the D\u00fcsseldorf MDS-registry","volume":"35","author":"Neukirchen","year":"2011","journal-title":"Leuk. Res."},{"issue":"8","key":"10.1016\/j.leukres.2022.106839_bib14","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1002\/cncr.22570","article-title":"Myelodysplastic syndromes: incidence and survival in the United States","volume":"109","author":"Ma","year":"2007","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.leukres.2022.106839_bib15","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1182\/blood-2010-05-282632","article-title":"Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project","volume":"116","author":"Sant","year":"2010","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.leukres.2022.106839_bib16","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/j.1445-5994.2011.02619.x","article-title":"Myelodysplastic syndrome in New Zealand and Australia","volume":"42","author":"Rodger","year":"2012","journal-title":"Intern Med. J."},{"issue":"18","key":"10.1016\/j.leukres.2022.106839_bib17","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1182\/blood-2014-04-522136","article-title":"Recent developments in myelodysplastic syndromes","volume":"124","author":"Bejar","year":"2014","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.leukres.2022.106839_bib18","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2188\/jea.JE20140042","article-title":"Incidence of myelodysplastic syndrome in Japan","volume":"24","author":"Chihara","year":"2014","journal-title":"J. Epidemiol."},{"issue":"3","key":"10.1016\/j.leukres.2022.106839_bib19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0145-2126(94)00135-W","article-title":"Clinical characteristics of Japanese patients with primary myelodysplastic syndromes: a co-operative study based on 838 cases","volume":"19","author":"Oguma","year":"1995","journal-title":"Leuk. Res."},{"issue":"5","key":"10.1016\/j.leukres.2022.106839_bib20","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0145-2126(98)00022-8","article-title":"Myelodysplastic syndromes in Thailand: a retrospective pathologic and clinical analysis of 117 cases","volume":"22","author":"Intragumtornchai","year":"1998","journal-title":"Leuk. Res."},{"issue":"8","key":"10.1016\/j.leukres.2022.106839_bib21","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s00277-011-1389-7","article-title":"First report of incidence of adult myelodysplastic syndrome in China","volume":"91","author":"Wang","year":"2012","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.leukres.2022.106839_bib22","unstructured":"Danckert B., Ferlay J., Engholm G., Hansen H.L., Johannesen T.B., Khan S., K\u00f8tlum J.E., \u00d3lafsd\u00f3ttir E., Schmidt L.K.H., Virtanen A. and Storm H.H. , 2019. NORDCAN: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries. 2019; Available at: http:\/\/www.ancr.nu. Accessed 10.06.2019."},{"issue":"5","key":"10.1016\/j.leukres.2022.106839_bib23","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3109\/02841861003782017","article-title":"NORDCAN \u2013 a Nordic tool for cancer information, planning, quality control and research","volume":"49","author":"Engholm","year":"2010","journal-title":"Acta Oncol."},{"key":"10.1016\/j.leukres.2022.106839_bib24","unstructured":"European standard population (ESP), 2013. Available at: \u3008https:\/\/ec.europa.eu\/eurostat\/cache\/metadata\/Annexes\/hlth_cdeath_esms_an1.pdf\u3009."},{"key":"10.1016\/j.leukres.2022.106839_bib25","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates","volume":"19","author":"Kim","year":"2000","journal-title":"Stat. Med."},{"issue":"6","key":"10.1016\/j.leukres.2022.106839_bib26","doi-asserted-by":"crossref","first-page":"782","DOI":"10.3109\/0284186X.2015.1127416","article-title":"Coverage and accuracy of myeloproliferative and myelodysplastic neoplasms in the finnish cancer registry","volume":"55","author":"Leinonen","year":"2016","journal-title":"Acta Oncol."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212622000650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212622000650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:01:57Z","timestamp":1758934917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212622000650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":26,"alternative-id":["S0145212622000650"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2022.106839","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence of myelodysplastic syndromes in Finland 1997\u20132016","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2022.106839","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106839"}}